Seroprevalence of SARS-Cov-2 in the Setting of a Non-dedicated COVID-19 Hospital in a Low CoV-2 Incidence Area: Implications for Surgery

• Sponsor: University of Cagliari (Other)
• Overall Status: Completed
• CT.gov ID: NCT04480580
• Collaborator: (none)
• Enrollment: 100
• Location: 1
• Actual Duration (Months): 3
• Patients Per Site Per Month: 33.1

Study Details

Study Description

Brief Summary

We have herein analysed the patients admitted to our Department that underwent serologic tests for SARS-CoV-2 either by Ab or RT PCR, to estimate the prevalence of COVID-19 in the setting of a non-dedicated COVID-19 hospital and in a low CoV-2 incidence area, and to evaluate if security measures are necessary for this context.

Condition or Disease	Intervention/Treatment	Phase
Covid19; Surgery; SARS (Severe Acute Respiratory Syndrome)	Diagnostic Test: SARS-CoV-2 Ab

Study Design

• Study Type: Observational
• Actual Enrollment: 100 participants
• Observational Model: Cohort
• Time Perspective: Retrospective
• Official Title: Seroprevalence of SARS-Cov-2 in the Setting of a Non-dedicated COVID-19 Hospital in a Low CoV-2 Incidence Area: Implications for Surgery
• Actual Study Start Date: Mar 30, 2020
• Actual Primary Completion Date: Apr 30, 2020
• Actual Study Completion Date: Jun 30, 2020

Arms and Interventions

Arm	Intervention/Treatment
Hospitalized patients	Diagnostic Test: SARS-CoV-2 Ab; Patient test for specific antibodies for SARS-CoV-2

Outcome Measures

Primary Outcome Measures

1. Seroprevalence of SARS-CoV-2 [3 months]

   Positivity of specific IgM or IgG

Eligibility Criteria

Criteria

• Ages Eligible for Study: N/A and Older
• Sexes Eligible for Study: All

Inclusion Criteria:

• Patients hospitalized during pandemic spread

Exclusion Criteria:

• Incomplete data

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	AOU Cagliari	Cagliari	CA	Italy	09100

Sponsors and Collaborators

• University of Cagliari

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Fabio Medas, Assistant Professor, University of Cagliari
• ClinicalTrials.gov Identifier: NCT04480580
• Other Study ID Numbers: COVID-SURG
• First Posted: Jul 21, 2020
• Last Update Posted: Jul 21, 2020
• Last Verified: Jul 1, 2020

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Keywords provided by Fabio Medas, Assistant Professor, University of Cagliari: SARS-CoV-2, surgery
• Additional relevant MeSH terms: COVID-19; Severe Acute Respiratory Syndrome

Study Results

No Results Posted as of Jul 21, 2020